A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy.
Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, Juneau P, Meyers K, Csimma C, Araujo T, Allen R, Parsons SA, Wozney JM, Lavallie ER, Mendell JR.
Wagner KR, et al. Among authors: flanigan km.
Ann Neurol. 2008 May;63(5):561-71. doi: 10.1002/ana.21338.
Ann Neurol. 2008.
PMID: 18335515
Clinical Trial.